University of Miami Sylvester Comprehensive Cancer Center
Overcoming Adaptive Therapy Resistance in AML: IRAK Signalling (via TLR9) Plays a Major Role in the Adaptive Resistance to FLT3 Inhibitors
Comments 0
Login to view comments.
Click here to Login
